DexCom
DXCM
#840
Rank
A$41.09 B
Marketcap
A$104.80
Share price
-0.41%
Change (1 day)
-26.03%
Change (1 year)

Earnings for DexCom (DXCM)

Earnings in 2025 (TTM): A$1.51 Billion

According to DexCom's latest financial reports the company's current earnings are A$4.51 Billion. In 2024 the company made an earning of A$1.04 Billion a decrease over its 2023 earnings that were of A$1.05 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for DexCom from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$1.51 B44.53%
2024 A$1.04 B-0.37%
2023 A$1.05 B78.13%
2022 A$0.59 B47.34%
2021 A$0.40 B-10.11%
2020 A$0.44 B88.27%
2019 A$0.23 B-258.48%
2018 -A$0.15 Billion189.94%
2017 -A$51.59 Million-44.24%
2016 -A$92.5 Million12.43%
2015 -A$82.27 Million165.58%
2014 -A$30.98 Million-25.61%
2013 -A$41.64 Million-48.11%
2012 -A$80.25 Million24.5%
2011 -A$64.46 Million
2008 -A$76.12 Million13.18%
2007 -A$67.26 Million-5.36%
2006 -A$71.07 Million52.08%
2005 -A$46.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.67 B 3,212.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.72 B 732.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$9.23 B 555.42%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
A$2.71 B 92.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
A$2.45 B 74.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-A$0.3 Billion-120.95%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
-A$1.64 Billion-216.18%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
A$0.87 B-38.21%๐Ÿ‡บ๐Ÿ‡ธ USA